Eupraxia Pharma将公开发行1270万股筹集约7000万美元

Core Viewpoint - Eupraxia Pharmaceuticals has priced its public offering of 12.7 million shares at $5.50 per share, raising approximately $70 million to advance its product pipeline and related commercial activities [1] Summary by Category - Company Actions - Eupraxia Pharmaceuticals is conducting a public offering of 12.7 million shares [1] - The offering price is set at $5.50 per share [1] - Financial Implications - The company aims to raise about $70 million through this offering [1] - Use of Proceeds - Funds raised will be utilized to advance the company's product pipeline and related commercial activities [1]